Julia M Adler
Overview
Explore the profile of Julia M Adler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
352
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee S, Yu Y, Trimpert J, Benthani F, Mairhofer M, Richter-Pechanska P, et al.
Nature
. 2025 Feb;
638(8052):E46.
PMID: 39905258
No abstract available.
2.
Long Y, Dimde M, Adler J, Vidal R, Povolotsky T, Nickl P, et al.
ACS Appl Mater Interfaces
. 2024 Nov;
16(49):67504-67513.
PMID: 39582136
Mucus is the first defense barrier against viruses in the human immune system. Inspired by the mucus structure, we designed a highly sulfated hydrogel to bind viruses and prevent infection...
3.
Friedrich V, Pennitz P, Wyler E, Adler J, Postmus D, Muller K, et al.
EBioMedicine
. 2024 Sep;
108:105312.
PMID: 39317638
Background: Translating findings from animal models to human disease is essential for dissecting disease mechanisms, developing and testing precise therapeutic strategies. The coronavirus disease 2019 (COVID-19) pandemic has highlighted this...
4.
Muhlemann B, Trimpert J, Walper F, Schmidt M, Jansen J, Schroeder S, et al.
Proc Natl Acad Sci U S A
. 2024 Jul;
121(32):e2310917121.
PMID: 39078681
Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) has developed substantial antigenic variability. As the majority of the population now has pre-existing immunity due to infection or vaccination, the use of...
5.
Peidli S, Nouailles G, Wyler E, Adler J, Kunder S, Voss A, et al.
Cell Rep
. 2024 Jun;
43(6):114328.
PMID: 38861386
A key issue for research on COVID-19 pathogenesis is the lack of biopsies from patients and of samples at the onset of infection. To overcome these hurdles, hamsters were shown...
6.
Bej R, Stevens C, Nie C, Ludwig K, Degen G, Kerkhoff Y, et al.
Adv Mater
. 2024 May;
36(32):e2401745.
PMID: 38815174
Mucus is a dynamic biological hydrogel, composed primarily of the glycoprotein mucin, exhibits unique biophysical properties and forms a barrier protecting cells against a broad-spectrum of viruses. Here, this work...
7.
Herwig S, Adler J, Vladimirova D, Trimpert J, Sehouli J, Cichon G
Vaccines (Basel)
. 2024 Mar;
12(3).
PMID: 38543882
During the COVID-19 pandemic, the early emergence of viral variants repeatedly undermined the effects of vaccination. Our aim here is to explore strategies for improving spike vaccine gene antigenicity by...
8.
Adler J, Vidal R, Langner C, Vladimirova D, Abdelgawad A, Kunecova D, et al.
Nat Commun
. 2024 Feb;
15(1):995.
PMID: 38307868
The development of effective SARS-CoV-2 vaccines has been essential to control COVID-19, but significant challenges remain. One problem is intramuscular administration, which does not induce robust mucosal immune responses in...
9.
Emanuel J, Papies J, Galander C, Adler J, Heinemann N, Eschke K, et al.
Front Pharmacol
. 2023 Aug;
14:1214351.
PMID: 37564181
The occurrence of immune-evasive SARS-CoV-2 strains emphasizes the importance to search for broad-acting antiviral compounds. Our previous study showed that root extract EPs 7630 has combined antiviral and immunomodulatory properties...
10.
Abdelaziz M, Raftery M, Weihs J, Bielawski O, Edel R, Koppke J, et al.
Front Immunol
. 2023 Jul;
14:1166765.
PMID: 37520530
Introduction: The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has highlighted the danger posed by human coronaviruses. Rapid emergence of immunoevasive variants and...